1. Home
  2. ENOV vs CENTA Comparison

ENOV vs CENTA Comparison

Compare ENOV & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • CENTA
  • Stock Information
  • Founded
  • ENOV 1995
  • CENTA 1955
  • Country
  • ENOV United States
  • CENTA United States
  • Employees
  • ENOV N/A
  • CENTA N/A
  • Industry
  • ENOV Fluid Controls
  • CENTA Consumer Specialties
  • Sector
  • ENOV Industrials
  • CENTA Consumer Discretionary
  • Exchange
  • ENOV Nasdaq
  • CENTA Nasdaq
  • Market Cap
  • ENOV 2.1B
  • CENTA 2.1B
  • IPO Year
  • ENOV 2008
  • CENTA 1993
  • Fundamental
  • Price
  • ENOV $38.21
  • CENTA $32.70
  • Analyst Decision
  • ENOV Buy
  • CENTA Strong Buy
  • Analyst Count
  • ENOV 4
  • CENTA 5
  • Target Price
  • ENOV $58.50
  • CENTA $41.50
  • AVG Volume (30 Days)
  • ENOV 952.0K
  • CENTA 408.7K
  • Earning Date
  • ENOV 05-01-2025
  • CENTA 05-07-2025
  • Dividend Yield
  • ENOV N/A
  • CENTA N/A
  • EPS Growth
  • ENOV N/A
  • CENTA N/A
  • EPS
  • ENOV N/A
  • CENTA 1.82
  • Revenue
  • ENOV $2,107,623,000.00
  • CENTA $3,222,363,000.00
  • Revenue This Year
  • ENOV $7.09
  • CENTA $2.92
  • Revenue Next Year
  • ENOV $6.38
  • CENTA $2.16
  • P/E Ratio
  • ENOV N/A
  • CENTA $17.70
  • Revenue Growth
  • ENOV 23.45
  • CENTA N/A
  • 52 Week Low
  • ENOV $35.14
  • CENTA $27.70
  • 52 Week High
  • ENOV $62.79
  • CENTA $41.03
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 43.35
  • CENTA 55.47
  • Support Level
  • ENOV $38.51
  • CENTA $30.14
  • Resistance Level
  • ENOV $40.70
  • CENTA $32.53
  • Average True Range (ATR)
  • ENOV 1.33
  • CENTA 0.90
  • MACD
  • ENOV 0.26
  • CENTA 0.06
  • Stochastic Oscillator
  • ENOV 49.87
  • CENTA 98.47

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: